Clinical trial
An Add-On Trial of Quetiapine in Patients With Bipolar Disorder and Cocaine…
NCT00223210 · University of Texas Southwestern Medical Center, Other · Completed
Key facts
| NCT number | NCT00223210 |
|---|---|
| Title | An Add-On Trial of Quetiapine in Patients With Bipolar Disorder and Cocaine Dependence |
| Official title | A Randomized, Double-Blind, Placebo-Controlled Add-On Trial of Quetiapine in Patients With Bipolar Disorder and Cocaine Dependence |
| Lead sponsor | University of Texas Southwestern Medical Center, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Bipolar Disorder, Cocaine Dependence |
| Intervention type | Drug |
| Interventions | Quetiapine, PLacebo |
| Enrollment | 100 |
| Start date | Nov 1, 2005 |
| Primary completion | Dec 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Sep 22, 2005 |
| Last update posted | Aug 20, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: